[
  {
    "ts": "2025-12-06T09:09:38+00:00",
    "headline": "Can Pfizer’s Recent Recovery Signal a Long Term Value Opportunity in 2025?",
    "summary": "Wondering if Pfizer is quietly turning into a value opportunity, or if the market is still too skeptical, you are not alone. That is exactly what this breakdown will unpack. After a rough few years, Pfizer's share price has ticked up 1.1% over the last week and 5.8% over the past month, even though it is still down 2.2% year to date and 40.1% over three years, with a modest 8.5% gain over the last year. Recent sentiment has been shaped by Pfizer's shifting pipeline strategy and portfolio...",
    "url": "https://finance.yahoo.com/news/pfizer-recent-recovery-signal-long-090938972.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f405bfff-96ea-3d01-9929-3ab3e364b3a4",
      "content": {
        "id": "f405bfff-96ea-3d01-9929-3ab3e364b3a4",
        "contentType": "STORY",
        "title": "Can Pfizer’s Recent Recovery Signal a Long Term Value Opportunity in 2025?",
        "description": "",
        "summary": "Wondering if Pfizer is quietly turning into a value opportunity, or if the market is still too skeptical, you are not alone. That is exactly what this breakdown will unpack. After a rough few years, Pfizer's share price has ticked up 1.1% over the last week and 5.8% over the past month, even though it is still down 2.2% year to date and 40.1% over three years, with a modest 8.5% gain over the last year. Recent sentiment has been shaped by Pfizer's shifting pipeline strategy and portfolio...",
        "pubDate": "2025-12-06T09:09:38Z",
        "displayTime": "2025-12-06T09:09:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-recent-recovery-signal-long-090938972.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-recent-recovery-signal-long-090938972.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]